Fulcrum Therapeutics
FULC
#8554
Rank
ยฃ0.18 B
Marketcap
ยฃ2.79
Share price
-1.06%
Change (1 day)
-52.00%
Change (1 year)

Revenue for Fulcrum Therapeutics (FULC)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of ยฃ63.74 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fulcrum Therapeutics from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 ยฃ63.74 M2795.44%
2023 ยฃ2.2 M-58%
2022 ยฃ5.24 M-63.07%
2021 ยฃ14.19 M119.32%
2020 ยฃ6.47 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA